<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Urology Product Guide &#187; Female Urology</title>
	<atom:link href="http://www.urologyproductguide.com/blog/category/female-urology/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.urologyproductguide.com/blog</link>
	<description>A comprehensive guide to urology products for medical professionals</description>
	<lastBuildDate>Fri, 23 Jul 2010 08:07:11 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>DNA Test May Improve Prostate Cancer Detection</title>
		<link>http://www.urologyproductguide.com/blog/2010/06/25/dna-test-may-improve-prostate-cancer-detection/</link>
		<comments>http://www.urologyproductguide.com/blog/2010/06/25/dna-test-may-improve-prostate-cancer-detection/#comments</comments>
		<pubDate>Fri, 25 Jun 2010 08:56:45 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Female Urology]]></category>
		<category><![CDATA[Prostate Management]]></category>
		<category><![CDATA[American Society of Clinical Oncology]]></category>
		<category><![CDATA[blood tests]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[prostate cancer]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/?p=198</guid>
		<description><![CDATA[DNA blood tests under development may provide a more accurate way to detect prostate and breast cancer, according to findings presented at the American Society of Clinical Oncology annual meeting. The findings, from a study of 575 subjects, showed that the tests have a 92% sensitivity and 100% specificity for detecting both malignancies. By comparison, [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.urologyproductguide.com/blog/wp-content/uploads/2010/06/American-Society-of-Clinical-Oncology.png"><img class="alignleft size-full wp-image-199" style="margin: 5px" src="http://www.urologyproductguide.com/blog/wp-content/uploads/2010/06/American-Society-of-Clinical-Oncology.png" border="0" alt="American Society of Clinical Oncology" width="200" height="96" /></a>DNA blood tests under development may provide a more accurate way to detect prostate and breast cancer, according to findings presented at the American Society of Clinical Oncology annual meeting. The findings, from a study of 575 subjects, showed that the tests have a 92% sensitivity and 100% specificity for detecting both malignancies. By comparison, PSA tests for prostate cancer have demonstrated an 85% sensitivity and 25%-35% specificity.</p>
<p>Read the full story <a href="http://www.renalandurologynews.com/dna-test-may-improve-prostate-cancer-detection/article/173047/" target="_blank">here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2010/06/25/dna-test-may-improve-prostate-cancer-detection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First Non-Invasive Technology For Treatment Of Uterine Fibroids Awarded MHLW Approval In Japan</title>
		<link>http://www.urologyproductguide.com/blog/2010/01/22/first-non-invasive-technology-for-treatment-of-uterine-fibroids-awarded-mhlw-approval-in-japan/</link>
		<comments>http://www.urologyproductguide.com/blog/2010/01/22/first-non-invasive-technology-for-treatment-of-uterine-fibroids-awarded-mhlw-approval-in-japan/#comments</comments>
		<pubDate>Fri, 22 Jan 2010 05:37:10 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Female Urology]]></category>
		<category><![CDATA[ExAblate(R)]]></category>
		<category><![CDATA[InSightec Ltd]]></category>
		<category><![CDATA[Labor and Welfare]]></category>
		<category><![CDATA[Ministry of Health]]></category>
		<category><![CDATA[MR-guided Focused Ultrasound]]></category>
		<category><![CDATA[uterine fibroids]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/?p=172</guid>
		<description><![CDATA[InSightec Ltd. announced that Japan&#8217;s Ministry of Health, Labor and Welfare (MHLW) has approved the company&#8217;s ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. ExAblate is currently the only noninvasive treatment for uterine fibroids approved for use in Japan. Approximately 25% Japanese women will develop symptomatic uterine fibroids, primarily [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.urologyproductguide.com/blog/wp-content/uploads/2010/01/InSightec-Ltd.png"><img class="alignleft size-full wp-image-173" src="http://www.urologyproductguide.com/blog/wp-content/uploads/2010/01/InSightec-Ltd.png" border="0" alt="InSightec Ltd" width="200" height="48" /></a>InSightec Ltd. announced that Japan&#8217;s Ministry of Health, Labor and Welfare (MHLW) has approved the company&#8217;s ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. ExAblate is currently the only noninvasive treatment for uterine fibroids approved for use in Japan. Approximately 25% Japanese women will develop symptomatic uterine fibroids, primarily during childbearing years. These benign tumors can significantly impair functionality and degrade quality of life resulting in significant work absences.</p>
<p>For the full story, <a href="http://www.medicalnewstoday.com/articles/175941.php" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2010/01/22/first-non-invasive-technology-for-treatment-of-uterine-fibroids-awarded-mhlw-approval-in-japan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Examines Outcome of Upper Urinary Tract Cancers</title>
		<link>http://www.urologyproductguide.com/blog/2009/11/27/study-examines-outcome-of-upper-urinary-tract-cancers/</link>
		<comments>http://www.urologyproductguide.com/blog/2009/11/27/study-examines-outcome-of-upper-urinary-tract-cancers/#comments</comments>
		<pubDate>Fri, 27 Nov 2009 12:41:27 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Female Urology]]></category>
		<category><![CDATA[renal pelvis]]></category>
		<category><![CDATA[The Journal of Urology]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[urinary tract urothelial carcinoma]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/?p=145</guid>
		<description><![CDATA[According to research published in the November issue of The Journal of Urology the location of the tumor in the renal pelvis compared to the ureter doesn&#8217;t predict cancer-specific mortality, in patients with upper urinary tract urothelial carcinoma (UTUC). The researchers found that patients with primary renal pelvis tumors were more likely to be female [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.urologyproductguide.com/blog/wp-content/uploads/2009/11/The-Journal-of-Urology.png"><img class="alignright size-full wp-image-146" style="margin: 5px" src="http://www.urologyproductguide.com/blog/wp-content/uploads/2009/11/The-Journal-of-Urology.png" border="0" alt="The Journal of Urology" width="200" height="55" /></a>According to research published in the November issue of The Journal of Urology the location of the tumor in the renal pelvis compared to the ureter doesn&#8217;t predict cancer-specific mortality, in patients with upper urinary tract urothelial carcinoma (UTUC). The researchers found that patients with primary renal pelvis tumors were more likely to be female than patients with ureteral primary tumors.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2009/11/27/study-examines-outcome-of-upper-urinary-tract-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New non-surgical test to diagnose uterine disorder</title>
		<link>http://www.urologyproductguide.com/blog/2009/09/04/new-non-surgical-test-to-diagnose-uterine-disorder/</link>
		<comments>http://www.urologyproductguide.com/blog/2009/09/04/new-non-surgical-test-to-diagnose-uterine-disorder/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 13:22:02 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Female Urology]]></category>
		<category><![CDATA[Reproductive Health]]></category>
		<category><![CDATA[Urology Diagnostics]]></category>
		<category><![CDATA[endometriosis]]></category>
		<category><![CDATA[fallopian tubes]]></category>
		<category><![CDATA[Ian Fraser at the University of Sydney]]></category>
		<category><![CDATA[infertility]]></category>
		<category><![CDATA[Maomar al-Jefout of Mu'tah University]]></category>
		<category><![CDATA[ovaries]]></category>
		<category><![CDATA[pain during sexual intercourse]]></category>
		<category><![CDATA[painful periods]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[uterine lining]]></category>
		<category><![CDATA[uterus]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/?p=103</guid>
		<description><![CDATA[A new study has indicated that endometriosis, in which cells from the lining of the uterus grow in other regions such as fallopian tubes and ovaries, can also be quickly and accurately identified by a small test. Researchers led by Ian Fraser at the University of Sydney and Maomar al-Jefout of Mu&#8217;tah University found that [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.urologyproductguide.com/blog/wp-content/uploads/2009/09/UoSydney.png"><img class="alignleft size-full wp-image-104" style="margin: 5px" src="http://www.urologyproductguide.com/blog/wp-content/uploads/2009/09/UoSydney.png" alt="UoSydney" width="200" height="43" /></a>A new study has indicated that endometriosis, in which cells from the lining of the uterus grow in other regions such as fallopian tubes and ovaries, can also be quickly and accurately identified by a small test. Researchers led by Ian Fraser at the University of Sydney and Maomar al-Jefout of Mu&#8217;tah University found that a small tissue sample taken from the uterine lining with a device inserted through the vagina works just as well. This condition of the uterus, which is linked to infertility, painful periods and pain during sexual intercourse, until now could only be detected through surgery.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2009/09/04/new-non-surgical-test-to-diagnose-uterine-disorder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hospital uses botox to treat overactive bladder</title>
		<link>http://www.urologyproductguide.com/blog/2008/09/17/hospital-uses-botox-to-treat-overactive-bladder/</link>
		<comments>http://www.urologyproductguide.com/blog/2008/09/17/hospital-uses-botox-to-treat-overactive-bladder/#comments</comments>
		<pubDate>Wed, 17 Sep 2008 07:13:46 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Bladder Access and Drainage]]></category>
		<category><![CDATA[Female Urology]]></category>
		<category><![CDATA[Blackpool Victoria Hospital]]></category>
		<category><![CDATA[botox]]></category>
		<category><![CDATA[neuro-toxin]]></category>
		<category><![CDATA[NICE approval]]></category>
		<category><![CDATA[overactive bladder]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/2008/09/17/hospital-uses-botox-to-treat-overactive-bladder/</guid>
		<description><![CDATA[The Blackpool Victoria Hospital has brought botox in use for the treatment of bladder problems. The cosmetic drug used to produce a smooth brow and wrinkle-free face is now being put to use in treating patients with overactive bladders. The response from patients has been good too. The procedure lasts for about 18 months and [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.urologyproductguide.com/blog/wp-content/uploads/2008/09/botox.png" align="left" height="109" hspace="5" vspace="5" width="200" />The Blackpool Victoria Hospital has brought botox in use for the treatment of bladder problems. The cosmetic drug used to produce a smooth brow and wrinkle-free face is now being put to use in treating patients with overactive bladders. The response from patients has been good too. The procedure lasts for about 18 months and the effects are completely reversible. <a href="http://www.botoxcosmetic.com/">Botox</a> has been given NICE approval to be used for this technique. A neuro-toxin that paralyzes the nerve endings which tell muscles to relax, botox can be injected directly into the bladder to treat an over-active bladder. It is a less invasive option.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2008/09/17/hospital-uses-botox-to-treat-overactive-bladder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
